We are live on ! Find out more
GENE

Genetic Technologies Ltd.
GENE

Delisted

GENE was delisted on the 16th of October, 2024.

Back to rankings

6 hedge funds and large institutions have $59K invested in Genetic Technologies Ltd. in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 6 → 6 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

43% less capital invested

Capital invested by funds: $103K → $59K (-$44K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$9.93K
2
Wells Fargo
Wells Fargo
California
+$431
3
Simplex Trading
Simplex Trading
Illinois
+$60

Top Sellers

Rank Fund Capital Flow
1
TSS
Two Sigma Securities
New York
-$12.1K
2
SA
Scarborough Advisors
Maryland
-$8.11K
3
Morgan Stanley
Morgan Stanley
New York
-$803
4
PWA
Provenance Wealth Advisors
Florida
-$57
5
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
-$3

GENE Hedge Fund Activity: Q4 2023 in Review

6 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q4 2023, worth a combined $59K — down 43% from $103K a quarter earlier.

Fund positioning in GENE was balanced in Q4 2023: 3 funds opened new positions, 3 closed out, 0 added to existing stakes and 2 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $9.93K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $12.1K sold.

  • 6 institutional investors held Genetic Technologies Ltd. (GENE) as of Q4 2023, unchanged from Q3 2023.
  • Funds reported $59K of Genetic Technologies Ltd. stock for Q4 2023, down 43% quarter-over-quarter.
  • 3 funds opened new Genetic Technologies Ltd. positions in Q4 2023 and 3 closed out, a net change of 0 holders.
  • The largest Genetic Technologies Ltd. buyer in Q4 2023 was UBS Group, an estimated $9.93K added.
  • The largest Genetic Technologies Ltd. seller in Q4 2023 was Two Sigma Securities, an estimated $12.1K sold.

Based on aggregated 13F filings for Q4 2023.